Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Assura delivers 'strong trading performance' in H1
(Sharecast News) - Real estate investment trust Assura said on Tuesday that it had delivered a "strong trading performance" over the first six months of the trading year, despite it being a "period of uncertainty" for the firm. Assura reported a like-for-like increase of 5.6% on £25.5m of rent roll reviewed, with a weighted average annual uplift of 2.9%. Assura said its portfolio now stands at 602 properties, with an annualised rent roll of £179.5m and a weighted average unexpired lease term of 12.3 years.
The FTSE 250-listed firm said construction was underway on a £18m primary care scheme in Weston-Super-Mare, pre-let to the NHS on a 25-year lease subject to five-yearly CPIH rent reviews, the first development funded through its £250m joint venture with USS, while construction will commence shortly on a new £19m independent hospital in Peterborough pre-let to a tier one independent health provider on a 25-year lease subject to three-yearly RPI rent reviews.
Assura also stated that it had an "attractive pipeline of opportunities" to support the healthcare system, sitting at £250m, all of which was capable of commencing in the next two years, and highlighted that its portfolio was
Earlier in September, the UK's competition watchdog formally launched an investigation into the recent merger of Primary Health Properties and Assura. The Competition and Markets Authority said the inquiry would assess the impact of the completed acquisition. It set a statutory deadline of 29 October for its phase one decision, although it noted that could be extended in "certain limited circumstances".
As of 0820 BST, Assura shares were down 0.64% at 46.70p.
Reporting by Iain Gilbert at Sharecast.com
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.